Bempedoic acid
Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor[1]. Bempedoic acid (ETC-1002) activates AMPK[2].
Product Specifications
CAS Number
738606-46-7
Product Name Alternative
ETC-1002; ESP-55016
UNSPSC
12352211
Hazard Statement
H302, H312, H332
Target
AMPK; ATP Citrate Lyase
Type
Reference compound
Related Pathways
Epigenetics; Metabolic Enzyme/Protease; PI3K/Akt/mTOR
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ETC-1002.html
Concentration
10mM
Purity
99.97
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O
Molecular Formula
C19H36O5
Molecular Weight
344.49
Precautions
H302, H312, H332
References & Citations
[1]Pinkosky SL, et al. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism. J Lipid Res. 2013 Jan;54 (1) :134-51.|[2]Filippov S, et al. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK. J Lipid Res. 2013 Aug;54 (8) :2095-108.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
AMPK
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
127805-PE 100 µL
HERC3 (Probable E3 Ubiquitin-protein Ligase HERC3, HECT Domain and RCC1-like Domain-containing Protein 3, KIAA0032) (PE)
Sign In for Pricing
View Details 
BP3054-50ug 50 µg
Recombinant Human Aldo-keto reductase family 1 member B1/AKR1B1 (C-His)
Sign In for Pricing
View Details